国际神经肌肉疾病大会(ICNMD)由世界神经病学联盟(WFN)神经肌肉疾病专业组(NMD)组织。自2014年以来每两年举办一次。ICNMD大会旨在为与会者提供关于神经肌肉疾病的最新观点，并提供交流机会以增加他们的国际经验和合作。（未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
The ICNMD International Congress on Neuromuscular Diseases is organized on behalf of the Specialty Group on Neuromuscular Diseases (NMD) of the World Federation of Neurology (WFN). Since 2014, the Congress has taken place in a two-year cycle.
The aim of the ICNMD Congresses is to offer attendees an updated view on neuromuscular disorders and that networking opportunities increase their international experience and collaborations. The scientific and program committee are invited from all continents around the world to enable this wide spectrum.
Topic Group 1 - Muscle Diseases. Genetic and Acquired Myopathies: Clinical Features, Pathophysiology, Therapy
- Dystrophinopathies
- Muscle Dystrophies (Non-Dystrophinopathies)
- Limb Girdle Muscular Dystrophies
- Facioscapulohumeral Muscular Dystrophies
- Oculopharyngeal Muscular Dystrophy
- Congenital Myopathies and congenital muscular dystrophies
- Myotonic Dystrophies
- Muscle Channelopathies and Related Disorders
- Metabolic Myopathies: Glycogen, Lipids and Mitochondrial Myopathies
- Distal Myopathies
- Myofibrillar Myopathies
- Inflammatory / Immune-mediated Myopathies including Inclusion Body Myositis (IBM)
- Hereditary Inclusion Body Myopathies (hIBM)
- Toxic / Endocrine / Other Acquired Myopathies
- Other Myopathies
- Advances in the treatment of muscle diseases.
Topic Group 2 - Diseases of Neuromuscular Junction: Clinical Features, Pathophysiology, Therapy
- Myasthenia Gravis
- Myasthenic Syndromes
- Congenital Myasthenic syndrome
- Advances in the treatment of Neuromuscular Junction diseases.
Topic Group 3 - Peripheral Neuropathies, including Cranial Nerves: Clinical Features, Pathophysiology, Therapy
- Hereditary Peripheral Neuropathies
- Immune-mediated Neuropathies
- Neuropathies Associated with Monoclonal Gammopathy / Paraneoplastic
- Metabolic, Toxic and Iatrogenic Neuropathies
- Infectious Peripheral Neuropathies (including Leprosy, HIV)
- Advances in treatment of Peripheral Neuropathies
- Small fibers and painful neuropathies
- Autonomic neuropathies
- Others
Topic Group 4 - Motor Neuron Diseases:
- ALS: Epidemiology and Clinical Features,
- ALS: Biology, Pathophysiology, Genetics
- ALS: Therapy
- Primary Progressive Lateral Sclerosis Variant
- non 5q SMA/distal SMA/ Hereditary Motor Neuropathies
- Post poliomyelitis Syndrome
- Bulbospinal muscular atrophy
- Biomarkers in MND
- Spinal Muscular Atrophies: Epidemiology and Clinical Features,
- Spinal Muscular Atrophies: Pathophysiology, Genetics
- Spinal Muscular Atrophies: Treatment
- Advances in treatment of Motor Neuron Diseases
Topic Group 5 –Diagnostic Methods and assessment in Neuromuscular Diseases
- Ultrasound
- MRI
- Electrophysiology
- Neuromuscular Pathology: Muscle and Nerve Biopsy
- Genetics in Neuromuscular Diseases including Biochemical/Molecular Techniques and next generation sequencing.
- Small Nerve Fibre Evaluation by Skin Biopsy
- Other Biomarkers
- Swallowing evaluation in neuromuscular diseases
- Cardiac and respiratory issues in neuromuscular diseases.
- Orthopedic issues in neuromuscular diseases.
- Outcome measures and clinimetry
Topic Group 6 - Basic Sciences in Neuromuscular Diseases
- Muscle Homeostasis / Muscle Regeneration
- Muscle Structure / Muscle Development / Muscle Growth
- Muscle Atrophy / Degeneration
- Nuclear Envelope / Nuclear Matrix of Muscle Cell
- Ion Channel Function in Neuron and Muscle
- Nerve development/nerve degeneration and regeneration
- Mechanisms of myelination and demyelination
- Immune Mechanisms in Neuromuscular Diseases
- Fundamental Approaches to Motor Neuron, Axon and Related Structures
- Neuromuscular Junction
- Axonal transport / axonal degeneration
- Myelin and Schwann cell
Topic Group 7 – COVID-19 related issues in Neuromuscular Diseases
Topic Group 8 - Patient Related Issues
Topic Group 9 – History
Topic Group 10 - Hereditary Ataxias/Spastic Paraplegias
